tiprankstipranks
Trending News
More News >
Abbvie (GB:0QCV)
:0QCV
UK Market

AbbVie (0QCV) Technical Analysis

Compare
9 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Abbvie’s (0QCV) Moving Averages Convergence Divergence (MACD) indicator is -1.48, suggesting Abbvie is a Buy.
Abbvie’s (0QCV) 20-Day exponential moving average is 186.74, while Abbvie’s (0QCV) share price is $179.78, making it a Sell.
Abbvie’s (0QCV) 50-Day exponential moving average is 189.27, while Abbvie’s (0QCV) share price is $179.78, making it a Sell.

AbbVie (0QCV) Pivot Points

May 16, 2025, 08:03 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
167.68
173.26
176.14
181.73
184.60
190.19
193.07
Fibonacci
173.26
176.50
178.49
181.73
184.96
186.96
190.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (0QCV) Moving Averages

May 16, 2025, 08:03 PM
Period
Simple
Exponential
MA5
185.36Sell
183.89Sell
MA10
188.09Sell
185.73Sell
MA20
184.90Sell
186.74Sell
MA50
194.33Sell
189.27Sell
MA100
188.49Sell
188.33Sell
MA200
186.36Sell
184.27Sell
Abbvie’s (0QCV) 10-Day exponential moving average is 185.73, while Abbvie’s (0QCV) share price is $179.78, making it a Sell.
Abbvie’s (0QCV) 100-Day exponential moving average is 188.33, while Abbvie’s (0QCV) share price is $179.78, making it a Sell.
Abbvie’s (0QCV) stock price is $179.78 and Abbvie’s (0QCV) 50-day simple moving average is 194.33, creating a Sell signal.
Abbvie’s (0QCV) stock price is $179.78 and Abbvie’s (0QCV) 100-day simple moving average is 188.49, creating a Sell signal.
Abbvie’s (0QCV) stock price is $179.78 and Abbvie’s (0QCV) 200-day simple moving average is 186.36, creating a Sell signal.

AbbVie (0QCV) Technical Indicators

May 16, 2025, 08:03 PM
Name
Value
Implied Action
RSI (14)
41.85
Neutral
STOCH (9,6)
25.69
Neutral
STOCHRSI (14)
30.48
Neutral
MACD (12,26)
-1.48
Buy
ADX (14)
26.20
Neutral
Williams %R
-86.20
Buy
CCI (14)
-59.15
Neutral
ATR (14)
6.69
-
Ultimate Oscillator
56.69
Neutral
ROC
<0.01
Buy
Abbvie’s (0QCV) Relative Strength Index (RSI) is 41.85, creating a Neutral signal.
Abbvie’s (0QCV) Trend Strength Indicator (ADX) is 26.20, creating a Neutral signal.
Abbvie’s (0QCV) Commodity Channel Index (CCI) is -59.15, creating a Neutral signal.
Abbvie’s (0QCV) Price Rate of Change (ROC) is <0.01, creating a Buy signal.

FAQ

Is 0QCV a Buy, Hold, or Sell?
Based on 0QCV’s technical indicators, 0QCV is a Sell.
    What is 0QCV’s RSI (14)?
    0QCV’s RSI (14) is 41.85, which suggests 0QCV is a Neutral.
      What is 0QCV’s MACD?
      0QCV’s MACD is -1.48, which suggests 0QCV is a Buy.
        What is 0QCV’s 5-day moving average?
        0QCV’s 5-day moving average is 185.36, which suggests 0QCV is a Sell.
          What is 0QCV’s 20-day moving average?
          0QCV 20-day moving average is 184.90, which suggests 0QCV is a Sell.
            What is 0QCV’s 50-day moving average?
            0QCV’s 50-day moving average is 194.33, which suggests 0QCV is a Sell.
              What is 0QCV’s 200-day moving average?
              0QCV’s 200-day moving average is 186.36, which suggests 0QCV is a Sell.
                What is 0QCV’s Williams % R (14)?
                0QCV’s Williams % R (14) is -86.20, which suggests 0QCV is a Buy.
                  What is 0QCV’s CCI (14)?
                  0QCV’s CCI (14) is -59.15, which suggests 0QCV is a Neutral.
                    What is the share price of Abbvie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis